← FDA Drug Approvals (Drugs@FDA)
PEG-3350, SODIUM SULFATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE, SODIUM ASCORBATE AND ASCORBIC ACID
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: TARO · Approved 2024-06-28
Drug application
- FDA Application #
ANDA207498- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- PEG-3350, SODIUM SULFATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE, SODIUM ASCORBATE AND ASCORBIC ACID
- Generic name
- Ascorbic Acid
- Active ingredients
- ASCORBIC ACID; POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM ASCORBATE; SODIUM CHLORIDE; SODIUM SULFATE
- Dosage form
- FOR SOLUTION
- Route
- ORAL
- Marketing status
- Discontinued
- Sponsor
- TARO
- First approval
- 2024-06-28
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown